Climb Bio director Thomas Stephen Basil disposes of $1,366,820 in common shares
CLYM•Director share sale reported
- Director Thomas Stephen Basil sold 100,000 shares of Climb Bio common stock on Sept. 15, 2026.
- Sale priced at a weighted average of USD 13.67 per share.
- Post-transaction holding totaled 467,969 shares.
